369 related articles for article (PubMed ID: 27689466)
1. Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.
Matsumura S; Ohta T; Yamanouchi K; Liu Z; Sudo T; Kojimahara T; Seino M; Narumi M; Tsutsumi S; Takahashi T; Takahashi K; Kurachi H; Nagase S
Cancer Biol Ther; 2017 Sep; 18(9):730-739. PubMed ID: 27689466
[TBL] [Abstract][Full Text] [Related]
2. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
3. The role of estrogen receptor alpha in mediating chemoresistance in breast cancer cells.
Jiang Z; Guo J; Shen J; Jin M; Xie S; Wang L
J Exp Clin Cancer Res; 2012 May; 31(1):42. PubMed ID: 22553917
[TBL] [Abstract][Full Text] [Related]
4. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
[TBL] [Abstract][Full Text] [Related]
5. ERα-targeted therapy in ovarian cancer cells by a novel estradiol-platinum(II) hybrid.
Brasseur K; Leblanc V; Fabi F; Parent S; Descôteaux C; Bérubé G; Asselin E
Endocrinology; 2013 Jul; 154(7):2281-95. PubMed ID: 23677930
[TBL] [Abstract][Full Text] [Related]
6. Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells.
Farooqui M; Geng ZH; Stephenson EJ; Zaveri N; Yee D; Gupta K
Mol Cancer Ther; 2006 Mar; 5(3):611-20. PubMed ID: 16546975
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
8. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor α attenuates therapeutic efficacy of paclitaxel on breast xenograft tumors.
Chang J; Sui M; Fan W
Breast Cancer Res Treat; 2012 Aug; 134(3):969-80. PubMed ID: 22374518
[TBL] [Abstract][Full Text] [Related]
10. Non-genomic estrogen/estrogen receptor α promotes cellular malignancy of immature ovarian teratoma in vitro.
Hung YC; Chang WC; Chen LM; Chang YY; Wu LY; Chung WM; Lin TY; Chen LC; Ma WL
J Cell Physiol; 2014 Jun; 229(6):752-61. PubMed ID: 24142535
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol regulates the cell viability promoted by 17β-estradiol or bisphenol A via down-regulation of the cross-talk between estrogen receptor α and insulin growth factor-1 receptor in BG-1 ovarian cancer cells.
Kang NH; Hwang KA; Lee HR; Choi DW; Choi KC
Food Chem Toxicol; 2013 Sep; 59():373-9. PubMed ID: 23810794
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
13. Anticipatory estrogen activation of the unfolded protein response is linked to cell proliferation and poor survival in estrogen receptor α-positive breast cancer.
Andruska N; Zheng X; Yang X; Helferich WG; Shapiro DJ
Oncogene; 2015 Jul; 34(29):3760-9. PubMed ID: 25263449
[TBL] [Abstract][Full Text] [Related]
14. Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.
Park SH; Cheung LW; Wong AS; Leung PC
Mol Endocrinol; 2008 Sep; 22(9):2085-98. PubMed ID: 18550773
[TBL] [Abstract][Full Text] [Related]
15. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
16. Estradiol promotes cell survival and induces Greb1 expression in granulosa cell tumors of the ovary through an ERα-dependent mechanism.
Cluzet V; Devillers MM; Petit F; Pierre A; Giton F; Airaud E; L'Hôte D; Leary A; Genestie C; Treilleux I; Mayeur A; Katzenellenbogen JA; Kim SH; Cohen-Tannoudji J; Chauvin S; Guigon CJ
J Pathol; 2022 Mar; 256(3):335-348. PubMed ID: 34860414
[TBL] [Abstract][Full Text] [Related]
17. ERα-dependent estrogen-TNFα signaling crosstalk increases cisplatin tolerance and migration of lung adenocarcinoma cells.
Cheng LC; Lin CJ; Chen PY; Li LA
Biochim Biophys Acta Gene Regul Mech; 2021 Aug; 1864(8):194715. PubMed ID: 34082140
[TBL] [Abstract][Full Text] [Related]
18. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.
La Rosa P; Pesiri V; Leclercq G; Marino M; Acconcia F
Mol Endocrinol; 2012 May; 26(5):762-74. PubMed ID: 22446104
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
